DEPLOYDatabase

Robot model

hinotori

surgicalcommercialby Medicaroid

Japan first domestically manufactured robotic-assisted surgery system, developed by Medicaroid (Kawasaki-Sysmex joint venture).

Track hinotori
Manufacturer
Medicaroid
Form factor
surgical
Maturity
commercial
Lifecycle
active
Deployments
5

The verified answer

As of Sep 2026, DEPLOY verifies hinotori, a surgical by Medicaroid (commercial): 5 verified deployments on record. 1 source back the record.

Regulatory status1 CE marking

hinotori holds 1 CE marking, per the DEPLOY registry.

See all 1 filings

Overview

Japan first domestically manufactured robotic-assisted surgery system, developed by Medicaroid (Kawasaki-Sysmex joint venture). Approved in Japan (2020), Singapore (2023), Malaysia (2024), Vietnam (2026), and CE-marked under MDR (July 2026). Authorized for urology, general surgery, gynecology, and thoracic surgery. Approximately 20,000 procedures performed globally.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Japan approval

2020 — first domestic manufacturer

CE mark

July 2026 (under MDR)

Asia approvals

Singapore (2023), Malaysia (2024), Vietnam (2026)

Specialties

Urology, general surgery, gynecology, thoracic surgery

Procedures

~20,000 globally

Data & sources

News coverage

1

1 source backing this record.View all →

Autonomy: verified vs claimed

What it actually does
Teleoperated (human-controlled)

Pricing

No verified price is on record for hinotori. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (5)

Free to use on your site, with a link back to DEPLOY.

hinotori on the deployment map

View the global map

Where hinotori is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Regulatory filings (1)

Safety record

No incidents on record for hinotori.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. https://www.medtechdive.com/news/medicaroid-wins-europes-ce-mark-for-hinotori-surgical-robot/824959/

Common questions

What is hinotori?
Japan first domestically manufactured robotic-assisted surgery system, developed by Medicaroid (Kawasaki-Sysmex joint venture). Approved in Japan (2020), Singapore (2023), Malaysia (2024), Vietnam (2026), and CE-marked under MDR (July 2026). Authorized for urology, general surgery, gynecology, and thoracic surgery. Approximately 20,000 procedures performed globally.
How much does hinotori cost?
hinotori's price is not publicly disclosed. DEPLOY has no verified price on record for hinotori from Medicaroid. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is hinotori actually deployed in the real world?
Yes. hinotori is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes hinotori?
hinotori is made by Medicaroid, based in Kobe, Hyogo Prefecture, Japan, founded in 2013.
Where is hinotori deployed?
5 verified deployments of hinotori are on the DEPLOY registry, including at Mahkota Medical Centre, Singapore General Hospital, Shizuoka Cancer Center.
Can you buy hinotori?
hinotori is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
Is hinotori approved by regulators?
hinotori has 1 regulatory record on the DEPLOY registry: CE marking, cleared. See the Regulatory filings section for each agency source.
What are alternatives to hinotori?
On the DEPLOY registry, comparable surgical robots to hinotori include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does hinotori compare to da Vinci (and Ion)?
hinotori and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. hinotori has 5 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is hinotori a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, hinotori ranks in roughly the top 17% of surgical models tracked by the registry.
What is hinotori's maturity stage?
hinotori is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is hinotori safe?
hinotori has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-09

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-09

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
secondary-trade-publication
Trade publication

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for hinotori.

Recent coverage

hinotori in third-party press

Medicaroid Obtains CE marking for hinotoriTM surgical robot system - Med-Tech Insights

Jul 16, 2026

Japan’s first robotic surgery system attains CE Mark for European propulsion - Mugglehead Investment Magazine

Jul 12, 2026

Medicaroid wins Europe’s CE mark for Hinotori surgical robot - MedTech Dive

Jul 10, 2026